<DOC>
	<DOCNO>NCT00442299</DOCNO>
	<brief_summary>The uremic syndrome mainly related retention host compound , due alter glomerular filtration factor renal dysfunction , e.g . tubular secretion . Uremic retention solute arbitrarily subdivide three different category accord physicochemical characteristic subsequent behaviour dialysis : ( ) small , water-soluble , non-protein bound compound , ( ii ) large middle molecule , mainly peptide ( iii ) small protein-bound compound ( 1 ) . Although direct proof lacking , several line evidence indicate albumin important carrier protein . Removal protein bind uremic retention solute limit . The Prometheus® system fractionate blood plasma cellular component , use albumin-permeable polysulfon filter ( AlbuFlow® ) specially design sieve coefficient curve ( 1.0 2-microglobulin , &gt; 0.6 albumin , &lt; 0.3 IgG , &lt; 0.1 fibrinogen &lt; 0.01 IgM ) . Due high sieve coefficient filter large molecule ( i.e . cut-off 250 kD ) molecules size albumin ( 69 kD ) easily pass blood secondary circuit fill isotonic sodium chloride solution , whereas large molecule like fibrinogen ( 340 kD ) pas filter . In secondary circuit filter plasma albumin-bound toxin flow one two adsorbers row maximize adsorption capacity putative liver toxin directly adsorb ( ` fractionate plasma separation adsorption ' FPSA ) . The purified plasma return blood side albumin filter . In order eliminate water-soluble toxin , blood thereafter undergoes hemodialysis use conventional high-flux dialyser . We hypothesise removal protein bound uremic retention solutes improved FPSA compare standard hemodialysis .</brief_summary>
	<brief_title>Albumin Dialysis End-Stage Renal Disease : Detoxification Capacity Impact Vascular Endothelial Function</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>&gt; 18 year age maintenance ( &gt; 3 month ) hemodialysis patient Stable access , blood flow least 250 mL/min Known hemodialysisrelated hypotension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>hemodialysis , urmeic retention solute , biocompatibility</keyword>
</DOC>